This goes to show that the trading update the company provided a few days ago was a near meaningless update because it made no reference to what the investment gain or loss was.
As it happened, the P&L was held back by a $4.7m mark-to-market losses on investments, ($2.7m in the DH23 and a further $2.0m in JH24).
Which, if you strip those out, instead of FY24 Pre-Tax Profit of $9.3m (split as: $2m in DH23 and $7.2m in JH24), you get Underlying Pre-Tax Profit of $ 13.9m ($4.6m in DH23 and, importantly, $9.3m for JH24).
So they exited the year at a half-yearly Pre-Tax run-rate of above $9.0m (or NPAT of $6.5m, => $13m annualized NPAT).
Yes, I know that EZL's earnings are not granular, so the notion of "annualising based on a period-end earnings run rate" is a bit of a flawed one. Nevertheless, even if one takes it as a merely indicative, as opposed to prescriptive, indicator, then it very much sounds like a level of profitability which doesn't match a company with an Enterprise Value of only $55m.
At this rate, on my calculations it is trading on ~3x EV/EBIT (and that is based on the interest income booked below the Operating line).
Sure, given the volatility of EZL's earnings an EV/EBIT of, say 12x, is not justifiable.
Nor even 10x. Or probably not even 8x.
But I think at least 5x or 6x is eminently defensible.
Which would equate to a share price of $1.20.
.
- Forums
- ASX - By Stock
- EZL
- Ann: Appendix 4E and Full Year Statutory Accounts
EZL
euroz hartleys group limited
Add to My Watchlist
0.50%
!
$1.00

Ann: Appendix 4E and Full Year Statutory Accounts, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.00 |
Change
0.005(0.50%) |
Mkt cap ! $164.8M |
Open | High | Low | Value | Volume |
99.5¢ | $1.06 | 99.0¢ | $448.0K | 446.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 15458 | 99.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.00 | 2946 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2847 | 0.990 |
1 | 2000 | 0.960 |
2 | 4210 | 0.950 |
2 | 21767 | 0.945 |
1 | 938 | 0.940 |
Price($) | Vol. | No. |
---|---|---|
1.000 | 2946 | 1 |
1.050 | 20000 | 1 |
1.055 | 13900 | 1 |
1.060 | 9996 | 2 |
1.100 | 41641 | 2 |
Last trade - 15.58pm 27/06/2025 (20 minute delay) ? |
Featured News
EZL (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online